Source: BioPortfolio

PCI Synthesis: PCI Synthesis Changes Name to Form Global CDMO

NewsThe move combines Novacap's CDMOÂsubsidiaries PCI Synthesis PCAS Uetikon and Proteus into a new entity to be known as SEQENS.Contributed Author

Read full article »
PCI Synthesis's Competitors | PCI Synthesis's News | PCI Synthesis's Financials
Stay up-to-date with the latest news on PCI Synthesis
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Jean-Noel David's photo - Managing Director of PCI Synthesis

Managing Director

Jean-Noel David

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on PCI Synthesis